Oct 16, 2017

Blackstone's big questions on infrastructure and retail investors

Ng Han Gua / AP

Earnings call for listed private equity firms are usually sleepy affairs, but this The Blackstone Group's phoner this Thursday could be different. Two big questions:

  1. Will Blackstone's mega-infrastructure fund ambitions be hampered by Trump-related changes since it was first announced?
  2. Can Blackstone really scale its retail investor base by lowering its wealth threshold?

Infrastructure: Blackstone in May announced that it was raising up to $40 billion for its first-ever infrastructure fund, including a $20 billion commitment from Saudi Arabia. Now we've got a Bloomberg report that the vehicle won't begin investing until it secures around $10 billion in outside commitments — which would temporarily reduce the Saudi check, given that it's basically a 1:1 match.

  • The earnings call question will be how fundraising has been affected by what appears to be a stalled U.S. infrastructure plan that was supposed to heavily leverage public-private partnerships. Back in May, the Trump Administration was still talking about infrastructure as a 2017 priority, and Blackstone boss Steve Schwarzman was still leading a presidential council of CEOs. Neither of those are still operable.

Retail: The WSJ has a front-pager today about how Blackstone is lowering its threshold for individual investors to participate some affiliated feeder funds, from $5 million in liquid assets to $1 million: "There were 7½ times more U.S. households with $1 million to $5 million in assets at the end of 2016 than there were households with $5 million to $25 million, according to market research firm Spectrem Group."

  • The earnings call question will be how Blackstone plans to attract these investors at scale, in an era in which low-fee index fund have become conventional gospel. Particularly given increased competition within this niche, with The Carlyle Group and Oppenheimer today announcing the launch a joint venture that will offer access to global private credit opportunities for those with at least $1 million in liquid assets. And, if it doesn't really scale, is this just viewed as the price of stage-setting for (maybe) someday being allowed to access the defined-contribution market?

Go deeper

GOP sees more hurdles for Trump as coronavirus crisis drags on

Photo: Alex Wong/Getty Images

Republicans are increasingly concerned not only about President Trump’s daily briefings but also his broader plan to ease the nation out of the virus crisis and back to work. This concern is acute — and spreading. 

Why it matters: Trump can easily address the briefing worries by doing fewer, but the lackluster bounce-back planning is what worries Republicans most. 

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

Go deeperArrow2 hours ago - Health